MARKET INTRODUCTION
Any disorder causing impaired kidney function that leads to chronic kidney disease and progress over a long period of time resulted into end-stage kidney disease (ESKD) in which the kidneys can no longer function on their own. It is also called as kidney failure. Factors contributing to the formation of End stage kidney disease are hypertension, diabetes, smoking, and aging. The most common cause is diabetes, whereas hypertension (high blood pressure) is the second most cause of ESKD. The treatment of ESKD or CKD includes kidney transplantation or dialysis to keep patient alive.
MARKET DYNAMICS
End stage kidney disease market is driving due to factors such as increasing number of patients suffering from kidney failure and the introduction of technologically advanced products, such as low maintenance dialysis equipment and artificial kidney. However, factor such as delay in the diagnosis of chronic kidney disease is expected to hamper the market growth.
MARKET SCOPE
The End stage kidney disease market analysis to 2028 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of End stage kidney disease market with detailed market segmentation by Treatment type, and end user. The End stage kidney disease market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in End stage kidney disease market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The End stage kidney disease market is segmented on the basis of Treatment type, and end user. Based on treatment type, market is segmented as Transplant, and Dialysis. The Dialysis segment is further subsegmented into wearable artificial kidney, hemodialysis, and peritoneal dialysis. Based on end user market can be segmented into Research and academic institutes, Hospital and Clinics, Dialysis centers.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the End stage kidney disease market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The End stage kidney disease market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting End stage kidney disease market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the End stage kidney disease market in these regions.
MARKET PLAYERS
The report covers key developments in the End stage kidney disease market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as treatment type launches, treatment type approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from End stage kidney disease market are anticipated to have lucrative growth opportunities in the future with the rising demand for End stage kidney disease in the global market. Below mentioned is the list of few companies engaged in the End stage kidney disease market.
The report also includes the profiles of key players in End stage kidney disease market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Nipro Corporation
- Fresenius Medical Care
- Baxter International, Inc.
- Medtronic Plc
- B. Braun Melsungen AG
- BD
- Asahi Kasei Medical Co., Ltd.
- Cantel Medical
- Nikkiso Co., Ltd.
- JMS Co. Ltd.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.